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The microbial mechanisms and key metabolites that shape the composition of the human gut microbiota are
largely unknown, impeding efforts tomanipulate dysbioticmicrobial communities toward stability and health.
Vitamins, which by definition are not synthesized in sufficient quantities by the host and can mediate funda-
mental biological processes in microbes, represent an attractive target for reshaping microbial communities.
Here, we discuss how vitamin B12 (cobalamin) impacts diverse host-microbe symbioses. Although cobalamin
is synthesized by some human gut microbes, it is a precious resource in the gut and is likely not provisioned
to the host in significant quantities. However, this vitaminmaymake an unrecognized contribution in shaping
the structure and function of human gut microbial communities.Introduction
The human gut harbors trillions of microbes, dominated by two
broad phylogenetic groups (Bacteroidetes and Firmicutes) that
collectively encode over 100-fold more genes than the human
genome (Lozupone et al., 2012; Qin et al., 2010). Furthermore,
genes encoded by an individual’s gut microbial community
also exhibit substantially greater interpersonal variation than
their host. For example, individual humans have been estimated
to be heterozygous for 100 loss-of-function gene variants in
their own genomes (MacArthur et al., 2012), whereas their micro-
biomes generally encode hundreds of thousands of genes that
are not present in the majority of sampled individuals: over 2
million microbiome-encoded genes are observed in less than
20%of individuals (Qin et al., 2010). Thesemetagenomic studies
suggest that the microbiota may represent an important factor
that contributes to disease predisposition and response to treat-
ment. However, the underlying factors and key metabolites that
shape microbial community variation are largely unknown, and
as a result, methods to rationally alter the composition of the
gut microbiota for therapeutic purposes remain elusive.
Biologists have long appreciated the contributions of the gut
microbiota to health. In fact, Pasteur proposed in 1885 that
animals would not be viable without their associated microbes
(Gordon and Pesti, 1971). Although the establishment of germ-
free mice, rats, and other mammals 60 years later disproved
this bold hypothesis, gnotobiotic (known life) studies comparing
germfree and conventional animals have revealed a tremendous
and wide-ranging impact of resident microbes on host develop-
ment, metabolism, immune responses, and behavior (Dantas
et al., 2013; Diaz Heijtz et al., 2011; Faith et al., 2010; Goodman
andGordon, 2010; Smith et al., 2007). These experiments quickly
indicated that one fundamental service of the gut microbiota is
production of vitamins for the host. Indeed, early studies empha-
sized the requirement for increased dietary vitamins K, B1
(thiamin), B6 (pyridoxine), B7 (biotin), B9 (folic acid), and B12
(cobalamin) for the health of germfree animals (Ikeda et al.,1979; Sumi et al., 1977;Wostmann, 1981;Wostmann andKnight,
1965).Members of the generaBifidobacterium and Lactobacillus
may play important roles in this regard (Lozupone et al., 2012).
Because vitamins (by definition) are not produced in sufficient
quantities by the host, are safely consumed by humans, and
often mediate fundamental biological processes in most cells,
including bacteria, these compounds represent attractive targets
for manipulating gutmicrobial community composition. Here, we
discuss important nuances in evaluating the potential role of
one vitamin, cobalamin, in mediating both host-microbe and
microbe-microbe interactions in the gut. This Perspective has
two goals: first, we review evidence for gut microbial contribution
to host cobalamin levels in diverse microbe-host symbioses and
present evidence that, in the case of humans, gut microbial com-
munities are likely competitors for dietary cobalamin, rather than
contributors of this essential vitamin to the host. Second, we pro-
pose a potential role for cobalamin and related cofactors (corri-
noids; Box 1 and Figure 1) in shaping the composition of human
gut microbial communities and their expressed functions.
Role of Microbial Cobalamin in Nonhuman Systems
Cobalamin is an unusual vitamin in that it is not made by plants
and instead is synthesized exclusively by bacteria and archaea
(Roth et al., 1996). However, eukaryotes can have both direct
and indirect requirements for cobalamin and other corrinoids
and can potentially be further influenced by corrinoid-dependent
metabolism by their gut microbiota (Figure 2). As with both bac-
teria and archaea, only some eukaryotic lineages encode corri-
noid-dependent enzymes (e.g., vertebrates, some protists and
invertebrates, but not plants, insects or fungi) (Roth et al.,
1996). Strikingly, like humans, the majority of eukaryotes that
require corrinoids have retained genes encoding corrinoid-
dependent methylmalonyl CoA mutase (MCM, EC 5.4.99.2)
and/or corrinoid-dependent methionine synthase (MetH, EC
2.1.1.13). These corrinoid-dependent genes are retained in
these eukaryotes despite the existence of corrinoid-independentCell Metabolism 20, November 4, 2014 ª2014 Elsevier Inc. 769
Box 1. Corrinoid Diversity in the Human Gut
Over a dozen corrinoids have been described that differ in the structure of the lower ligand, a portion of the molecule that plays an
indirect role in the reactions catalyzed by corrinoid-dependent enzymes (Figure 1). Of these, eight have been found in the human
gut in varying proportions (Allen and Stabler, 2008). Although all corrinoids are formally capable of performing both radical-medi-
ated reactions and methyl group transfers via chemistry in the upper ligand (labeled as R in Figure 1) (Kra¨utler, 2005), humans and
many bacteria are restricted in the corrinoids they can use (Keller et al., 2013; Mok and Taga, 2013; Rosenblatt and Fenton, 1999;
Yi et al., 2012). Elaborate mechanisms exist that allow cobalamin entry into human cells while blocking the absorption of other
corrinoids, thereby shielding corrinoid-dependent enzymes from exposure to corrinoids that cannot be used as cofactors (Nielsen
et al., 2012). Likewise, bacteria that rely on corrinoid import rather than de novo biosynthesis must have mechanisms of acquiring
the specific corrinoids that function in their metabolism or the ability to remodel other corrinoids (Gray and Escalante-Semerena,
2009; Men et al., 2014a; Seth and Taga, 2014; Yi et al., 2012). Notably, gut microbes possibly remodel 80% of dietary cobalamin
based on supplementation studies (Allen and Stabler, 2008; Brandt et al., 1977). Mechanisms for corrinoid export have not been
identified in bacteria.
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catalyzes the interconversion of R-methylmalonyl-CoA and suc-
cinyl-CoA, a step in the metabolism of several branched chain
amino acids, fatty acids, cholesterol, and sugars to propionate
(Banerjee andChowdhury, 1999). In eukaryotes, this process pri-
marily occurs in the mitochondria (Frenkel and Kitchens, 1975).
MetH catalyzes the final step in the biosynthesis of methionine.
This reaction involves the transfer of amethyl group from another
cofactor, methyltetrahydrofolate, to the substrate, homocy-
steine (Matthews, 1999). In addition to MCM and MetH, some
eukaryotes also encode a corrinoid-dependent ribonucleotide
reductase (NrdJ/RNR II, EC 1.17.4.1) (Torrents et al., 2006).
This enzyme is critical for DNA synthesis as it is responsible for
the synthesis of deoxynucleotides (dNDP or dNTP) from ribonu-
cleotides (NDP or NTP) (Roth et al., 1996). The essential nature of
these pathways makes many eukaryotes dependent on microbi-
al corrinoids.
Although most plants neither produce nor require cobalamin,
nearly half of all algae require this vitamin (Croft et al., 2005; Hel-
liwell et al., 2011). These algae use cobalamin as a cofactor for
MCM, MetH, and/or RNR II (Helliwell et al., 2011). Many species
that do not require cobalamin have been found to encode MetE,
the cobalamin-independent isozyme of MetH, facilitating growth
in cobalamin-depleted conditions (Helliwell et al., 2011). Average
free cobalamin levels in marine systems are too low to support
cobalamin-dependent algal growth in vitro; however, coculture
with cobalamin producing bacteria can rescue growth (Croft
et al., 2005). Some of these bacteria colonize the extracellular
mucus layers surrounding algal cells. This close, physical asso-
ciation likely promotes exchange of algal photosynthates and
bacterial cobalamin, forming a mutualism (Croft et al., 2005).
Notably, this requirement is not neatly divided across the algal
phylogenetic tree and is likely the result of multiple independent
losses of MetE or MetH from an ancestor that encoded both
enzymes (Helliwell et al., 2011). Differences in cobalamin avail-
ability and cobalamin-independent metabolic pathways are pre-
sumed to have contributed to the heterogeneous occurrences
of cobalamin-requiring enzymes in algae (Helliwell et al., 2011;
San˜udo-Wilhelmy et al., 2012). Similar mutualisms have been
predicted in marine sponges and their associated microbes
(Siegl et al., 2011; Thomas et al., 2010). It is unclear if algae or
sponges can use corrinoids other than cobalamin.770 Cell Metabolism 20, November 4, 2014 ª2014 Elsevier Inc.In nematodes, including the model Caenorhabditis elegans,
cobalamin limitation results in reduced fertility and longevity
and recapitulates symptoms of cobalamin deficiency in humans
(Bito et al., 2013). C. elegans feeds on soil- and plant-associated
bacteria that can colonize the gut (Fe´lix and Duveau, 2012).
As a result, the bacterial diet determines cobalamin status in
C. elegans: worms fed with bacteria that produce cobalamin
radically alter gene expression and show accelerated develop-
ment and reduced mortality (MacNeil et al., 2013; Watson
et al., 2014). In this system, increased MCM activity prevents
the toxic buildup of propionic acid, reducing mortality. Further,
MetH activity enhances the production of S-adenosylmethio-
nine, which accelerates development, leading to an early cessa-
tion of egg laying and, consequently, reduced fertility (Watson
et al., 2014). Resident gut microbes that produce cobalamin
are similarly important in several freshwater fish species by obvi-
ating the need for dietary cobalamin (Sugita et al., 1991). One of
these cobalamin-producing microbes, Cetobacterium somerae,
is ubiquitous in wild and laboratory-reared zebrafish, suggesting
a possible metabolic importance (Roeselers et al., 2011).
Eukaryotes that do not encode cobalamin-dependent en-
zymes can maintain an indirect requirement for cobalamin if
the vitamin is essential for microbial symbionts they carry. For
example, neither plants nor insects directly require cobalamin
(Dadd, 1973; Roth et al., 1996), but in each of these lineages
symbioses with bacteria have evolved that rely on this essential
cofactor. Several legume species including Medicago sativa
(alfalfa) form intracellular associations with rhizobial bacteria
such as Sinorhizobium meliloti. S. meliloti resides within special-
ized root structures called nodules, where it fixes atmospheric
nitrogen and significantly contributes to plant growth under
nitrogen-limiting conditions (Jones et al., 2007). Successful
colonization of these nodules by S. meliloti is dependent on
cobalamin for ribonucleotide reductase (NrdJ) and methionine
synthase (MetH) activity (Taga and Walker 2010; Campbell
et al., 2006). Consequently, cobalamin deficiency severely
inhibits plant growth under nitrogen-limiting conditions due to
the lack of nitrogen fixation by its bacterial partner (Campbell
et al., 2006; Taga and Walker, 2010).
Numerous insects have forged intracellular, nutritional symbi-
oses with bacteria (Moran et al., 2008). Cicadas, for example,
feed on xylem sap, an incredibly poor nutritional source. To
Figure 1. Representative Examples of
Corrinoid Structural Diversity
See Allen and Stabler, 2008 and Renz, 1999.
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nine) missing from this diet, these insects maintain a cosymbio-
sis with two bacterial species, Sulcia muelleri (Bacteroidetes)
and Hodgkinia cicadicola (Alphaproteobacteria) (McCutcheon
et al., 2009). H. cicadicola synthesizes methionine via its cobal-
amin-dependent MetH enzyme; as a result, it maintains 13 genes
for corrinoid biosynthesis in its diminutive 144-kb genome
(McCutcheon et al., 2009). Without these enzymes or some die-
tary change, all three members of this tripartite symbiosis would
likely die out.
Gut Microbes Are Unlikely to Provide Significant
Sources of Cobalamin to Humans
In humans, cobalamin limitation can result from both uptake dis-
orders (including pernicious anemia, an autoimmune loss of the
cobalamin-uptake protein intrinsic factor that is fatal if untreated)
as well as dietary deficiencies (Stabler and Allen, 2004). The
physiologic and neurologic consequences of cobalamin limita-
tion and cobalamin trafficking disorders have been discussed
in numerous excellent reviews (Alpers and Russell-Jones,
2013; Gherasim et al., 2013; Rosenblatt and Fenton, 1999).
Although corrinoids are abundant in the large intestine due to
the activity of the gut microbiota, multiple factors prevent
humans from acquiring significant levels of cobalamin from this
source. First, cobalamin produced by gut microbes represents
less than 2% of the total corrinoid content in feces (Allen and
Stabler, 2008). Further, cobalamin produced in the colon, where
microbial numbers are highest, is not bioavailable because the
receptors necessary for absorbing the vitamin are found in
the small intestine, upstream of the site of corrinoid production
(Seetharam and Alpers, 1982). A notable exception is found in
mammals that practice coprophagy: these animals receive the
benefit of microbial cobalamin production in the large intestine
by consuming their feces, which localizes microbial cobalamin
(and other vitamins) to the upper part of the digestive tract where
it can be absorbed (Mickelsen, 1956). Furthermore, ruminants
are able to absorb cobalamin produced by microbes that reside
in the rumen, a microbe-rich digestive organ located upstream
of the small intestine (Girard et al., 2009). Perhaps coprophagic
and ruminant animals might thus select for gut microbes thatCell Metabolism 20,produce cobalamin rather than other
corrinoids, while other species would not
benefit from such enrichment. Indeed,
the cobalamin content of bovine rumen
(38% of total corrinoids) is substantially
higher than that of human feces (Fig-
ure 3A) (Girard et al., 2009).
In humans, diet is instead more likely
to constitute the primary source of
cobalamin. Given that cobalamin is not
found in plants, animal products are the
main source of cobalamin for most
individuals. It is for this reason that vege-tarians, and especially vegans, are more commonly found to
have low serum levels of cobalamin (Antony, 2003). The edible
macroalgaPorphyra yezoensis (commonly known as purple laver
or nori) has been found to contain corrinoid levels sufficient to
reverse the effects of cobalamin deficiency in rats (Takenaka
et al., 2001). Cobalamin has also been reported to be present
at lower levels in other non-animal foods including other edible
algae, some mushrooms, and fermented foods such as tempe,
kimchi, and tea (Watanabe et al., 2014).
Several other dietary items have previously been reported to
contain cobalamin, but more thorough chemical analyses later
revealed that other corrinoids were present. Much of the confu-
sion about the availability of cobalamin in foods and probiotics
is derived from ambiguity in themethods used tomeasure cobal-
amin. The classical method of measuring cobalamin levels is
a microbiological bioassay in which the growth of a corrinoid-
dependent organism such as Lactobacillus spp. or Euglena
gracilis is used as a proxy (Raven et al., 1972). Bioassays are
still commonly used today because of their sensitivity and con-
venience. However, it is clear that these assays cannot distin-
guish cobalamin from other corrinoids, because several different
corrinoids can be used as cofactors by the bioassay strains.
Assays with higher specificity for cobalamin have also been
developed that use purified intrinsic factor, the mammalian pro-
tein with the highest selectivity for cobalamin (Lau et al., 1965).
However, to our knowledge, not all of the known naturally
occurring corrinoids have been testedwith this assay. The recent
development of liquid chromatography-mass spectrometry
methods for corrinoid measurements has enabled the identifi-
cation of specific corrinoids in biological samples (Allen and
Stabler, 2008; Men et al., 2014b). The use of such methods
has revealed that food-associated bacteria previously thought
to provide cobalamin, such as the probiotic bacterium Lactoba-
cillus reuteri and the edible cyanobacterium Arthrospira (formerly
Spirulina) platensis, actually produce only pseudo-cobalamin
([Ade]Cba), which cannot be used by humans (Santos et al.,
2007; Tanioka et al., 2010).
Indeed, humangutmicrobesare likely topresentdirect compe-
tition with their host for cobalamin. The great majority of human
gut microbial species are predicted to require exogenousNovember 4, 2014 ª2014 Elsevier Inc. 771
Figure 2. Microbial Corrinoid Metabolism in the Gut
In coprophagic and ruminant animals, gut microbes provide a direct source of cobalamin (direct effect) (Girard et al., 2009). In some insects, corrinoids are
essential cofactors for obligate symbionts that provide key nutrients to the host (indirect effect) (McCutcheon et al., 2009). Competition and exchange of cor-
rinoids likely shape gut microbial community composition and expressed functions in humans and other animals (microbiome remodeling) (Allen and Stabler,
2008; Goodman et al., 2011; Seth and Taga, 2014).
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bacterial loads in their small intestines tend tohave lowcobalamin
status (Albert et al., 1980;Brandt et al., 1977;Murphyet al., 1986),
possibly due to either competition for cobalamin between the
host and microbes, or an overabundance of corrinoids other
than cobalamin. This observation is particularly notable given
that several bacteria isolated from the small intestine are capable
of synthesizing corrinoids in vitro (Albert et al., 1980). Further,
bacterial cells and purified intrinsic factor bind cobalamin with
similar affinities (Giannella et al., 1971, 1972). Together, these ob-
servations suggest that gut microbes likely compete for dietary
cobalamin in the small intestine. Whether or not small intestinal
microbial community configurations enriched in corrinoid scav-
engers contribute to cobalamin deficiencies in predisposed indi-
viduals (due to diet or genetic factors) is unknown.772 Cell Metabolism 20, November 4, 2014 ª2014 Elsevier Inc.A Potential Role for Corrinoids in Gut Microbial Ecology
There is great interest in developing ways of manipulating the
microbiota to promote health. There are presently no effective
methods of controlling the composition of microbes in the hu-
man gut, with the exception of antibiotic therapy, which targets
broad taxonomic groups, or fecal transplantation, in which the
entire microbiota is replaced with that of another individual
(Dethlefsen et al., 2008; Seekatz et al., 2014). Treatment with
probiotics, live bacteria ingested for the purpose of altering the
composition or metabolism in the gut, can improve symptoms
of gastrointestinal disease in some cases, though these probiotic
organisms may not become integrated as members of the
microbiota (Brigidi et al., 2000; McNulty et al., 2011).
Based on recent studies of the role of corrinoids in the human
gut, we propose that targeted manipulations of the gut
Figure 3. Corrinoid Composition of Microbial Communities Measured by LCMS
(A) The average corrinoid composition of fecal samples from 18 humans in the absence of cobalamin supplementation (Human); a groundwater enrichment
community amended with trichloroethene (GW); and bovine rumen (Rumen) is shown (adapted with permission from Allen and Stabler, 2008; Girard et al., 2009;
Men et al., 2014b).
(B) Corrinoid composition of fecal samples from 20 individuals (adapted with permission from Allen and Stabler, 2008). Asterisks indicate individuals supple-
mented daily with%25 mg cobalamin. Double asterisks indicate individuals supplemented daily with%1,000 mg cobalamin. Corrinoid abbreviations are defined
in Box 1.
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corrinoids. This hypothesis is based on the following observa-
tions. First, over 80% of sequenced human gut bacteria are pre-
dicted to use corrinoids, but less than 25% have the genetic ca-
pacity to synthesize these molecules (Degnan et al., 2014);
second, human fecal samples have been found to contain up
to eight distinct corrinoids (Allen and Stabler, 2008). Third, only
a fraction of the corrinoids available in a microbial community
can be used by a given organism, because corrinoid-dependent
enzymes have native specificity for their preferred cofactors
(Keller et al., 2013; Mok and Taga, 2013; Yi et al., 2012). Fourth,
corrinoids other than cobalamin are poorly recognized by human
intrinsic factor, the key protein required for transport of cobal-
amin from the lumen of the small intestine. Finally, corrinoids
are synthesized exclusively by bacteria and archaea, unlike
many other vitamins that are also prevalent in plant-based
dietary components (Roth et al., 1996). Thus, because different
bacteria require distinct groups of corrinoids, we hypothesize
that microbial communities can be manipulated by altering the
levels of particular corrinoids.
An analysis of the corrinoid composition of fecal samples of
20 individuals by Allen and Stabler (2008) revealed differences
in both the total corrinoid levels and the proportion of each
corrinoid (Figure 3B). It still remains to be tested whether these
differences are correlated with distinct microbial signatures
in these communities. For example, a corrinoid found almost
exclusively in methanogens, 5-hydroxybenzimidazolylcobamide
([5-OHBza]Cba) (Pol et al., 1982; Ryzhkova and Briukhanov,
2009), was detected in only 30% of the samples analyzed.
It would be interesting to test whether the presence or amount
of this corrinoid correlates with the abundance or metabolic
activity of methanogenic archaea, which are also found inapproximately 30%of individuals (Hansen et al., 2011). Similarly,
the levels of p-cresolylcobamide ([p-Cre]Cba), a corrinoid only
known to be synthesized by Veillonellaceae, could be reflective
of the abundance of this taxon (Chan and Escalante-Semerena,
2011; Men et al., 2014a, 2014b). Despite the observed differ-
ences among these individuals, a much greater difference is
seen between the human fecal samples and those from bovine
rumen and a trichloroethene (TCE)-containing groundwater
enrichment, suggesting that the human gut environment
selects for microbes that produce a particular set of corrinoids
(Figure 3A) (Girard et al., 2009; Men et al., 2014b). However, it
remains to be determined whether a broader diversity of corri-
noid profiles can be found in individuals with greater differences
in diet, lifestyle, or geographic location.
Allen and Stabler’s landmark study of corrinoids in human
fecal samples also revealed the effect of high doses of cobalamin
on the corrinoid composition of the gut (Allen and Stabler, 2008).
Individuals who ingested 1 to 2 mg cobalamin per day (nearly
1,000-fold higher than the recommended daily allowance in the
USA) not only had higher levels of this vitamin in the feces, as
would be expected if some of the supplement was not absorbed
in the small intestine, but also had high levels of nearly all other
corrinoids (Figure 3B). Furthermore, when examined over
time in a single individual, the increase in corrinoid levels was
found to be transient, as each corrinoid returned to the original
level after only 10 days. The increase in total corrinoid levels
following cobalamin supplementation is indicative of corrinoid
remodeling, in which the lower ligand of a corrinoid is removed
and another is attached (Gray and Escalante-Semerena, 2009).
Corrinoid remodeling has been observed in archaea and
bacteria grown in pure culture and is thought to be a mechanism
of obtaining specific corrinoids needed for metabolismCell Metabolism 20, November 4, 2014 ª2014 Elsevier Inc. 773
Table 1. Corrinoid-Dependent Enzymes in Humans and Their Gut Microbiota
Ortholog Humans
Gut
Microbes
Percent of
Gut Microbes Protein Description EC No.
MetH + + 67% B12-dependent methionine synthase 2.1.1.13
MCM/SpcA/MutAB + + 25% Methylmalonyl-CoA mutase 5.4.99.2
RNR II/NrdJ  + 35% Vitamin B12-dependent ribonucleotide reductase 1.17.4.1
GlmES  + 8% Glutamate mutase, methylaspartate mutase 5.4.99.1
Mgm  + 1% 2-methyleneglutarate mutase 5.4.99.4
IcmAB/IcmF/Hcm  + 4% Isobutyryl-CoA mutase/2-hydroxyisobutyryl-CoA mutase 5.4.99.13/5.4.99.-
EutBC  + 17% Ethanolamine ammonia lyase 4.1.3.7
PduCDE  + 11% Propanediol dehydratase/Glycerol dehydratase 4.2.1.28/4.2.1.30
KamED  + 8% Beta-lysine 5,6-aminomutase 5.4.3.3
OraSE  + 2% D-orinthine 4,5-aminomutase 5.4.3.5
QueG  + 33% Epoxyqueuosine reductase no EC
PceA  + 1% Tetrachloroethene reductive dehalogenase 1.97.1.8
AcsECD  + 4% CO dehydrogenase corrinoid/iron-sulfur protein complex no EC
Mta/Mtt  + 30% Methanol/methylamine/trimethylamine methyltransferases 2.1.1.247
HpnR/Hyp.  + 43% B12-binding domain/radical SAM domain proteins no EC
See Degnan et al., 2014.
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2009; Yi et al., 2012). The observation that corrinoid remodeling
allows the gut microbiota to maintain a stable corrinoid compo-
sition points to the robustness of this community and an impor-
tant challenge in modulating corrinoid levels by supplementation
with a biologically active corrinoid. Alternative approaches could
be to provide synthetic corrinoid analogs that are not recognized
by the remodeling machinery, or lower ligand bases to be
incorporated to form desired corrinoids (known as guided
biosynthesis). It would be interesting to examine the microbial
composition and gene expression profiles following cobalamin
supplementation as a means to understand the short-term and
long-term effects of perturbations of corrinoid metabolism.
Corrinoids Play a Role in the Physiology of Most
Human Gut Microbes
Corrinoids are best known for their roles as cofactors for en-
zymes that perform radical rearrangements or methyl transfer
reactions. MCM and MetH, the only two cobalamin-dependent
enzymes present in humans, are also among the most abundant
corrinoid-dependent enzymes in the human gut microbiome
(Degnan et al., 2014). The conversion of succinyl-CoA to methyl-
malonyl-CoA by MCM and the subsequent decarboxylation to
propionyl CoA generates CO2, which has been hypothesized
to facilitate respiration in anaerobic environments such as the
gut that contain low levels of alternate electron acceptors (Fisch-
bach and Sonnenburg, 2011; Macy et al., 1978). During this pro-
cess, Na+ is pumped out of the cell, establishing a gradient that
can be exploited for ATP synthesis (Dimroth, 1987). One third of
the bacterial species that contain aMetH homolog apparently do
not depend on corrinoids for MetH activity under at least some
conditions, because they also contain a homolog of MetE (De-
gnan et al., 2014). However, numerous additional genes encod-
ing a variety of other corrinoid-dependent enzymes not found in
human cells are also present in the human gut microbiome and774 Cell Metabolism 20, November 4, 2014 ª2014 Elsevier Inc.contribute to specific metabolic processes (Table 1). For
example, the corrinoid-dependent enzyme ethanolamine
ammonia lyase, which is present in 17% of sequenced human
gut commensals (Degnan et al., 2014), allows bacteria to use
ethanolamine, a breakdown product of the membrane phospho-
lipid phosphatidylethanolamine that is found in the gut, as a car-
bon and nitrogen source (Garsin, 2010). As described below, the
large number of other genes in the gut whose expression is
potentially regulated by corrinoids suggests that additional cor-
rinoid-dependent processes remain to be discovered.
Corrinoid-Dependent Gene Regulation in the
Gut Microbiome
In addition to their roles as enzyme cofactors, corrinoids also act
as regulators of gene expression in diverse bacteria, including
human gut species. Riboswitches are regulatory RNA elements
commonly found in the 50 UTR of gene transcripts that modulate
gene expression by binding specific small molecule metabolites
such as vitamins or amino acids (Tucker and Breaker, 2005). The
change in RNA secondary structure caused by binding the small
molecule ligand affects transcription or translation of the
attached mRNA (Nahvi et al., 2002; Waters and Storz, 2009).
Corrinoid riboswitches (classified as cobalamin or adenosylco-
balamin riboswitches) have been found to act by ligand-induced
transcriptional or translational attenuation in select model
bacteria (Vitreschak et al., 2003). In these organisms, most of
the genes regulated by riboswitches are involved in corrinoid
biosynthesis or transport. Gut microbes that are dependent on
corrinoids frequently encode multiple corrinoid riboswitches,
with nearly 41% of species recently analyzed possessing R3
(106/260) and some with as many as 17 (Degnan et al., 2014).
Apart from corrinoid biosynthesis and transport genes, these
mRNA regulators in the human microbiome are found upstream
of a variety of corrinoid-dependent genes and their corrinoid-
independent isozyme counterparts such as metE and
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et al., 2003). Strikingly, known corrinoid biosynthesis, corrinoid
transport, corrinoid-dependent enzymes, and their corrinoid-in-
dependent isozymes constitute only half of the nearly 4,000
genes putatively regulated by corrinoid riboswitches in
sequenced human gut microbial species (Degnan et al., 2014).
As such, many additional genes are potentially subject to
expression modulation in response to corrinoid availability. For
example, more than half of the sequenced Bacteroidetes ge-
nomes encode a corrinoid riboswitch-regulated multisubunit
carboxylase gene cluster (EC 6.4.1.-). Although the substrate is
uncertain (possibly propionate; Rodionov et al., 2003), the wide-
spread regulation of this locus in response to corrinoids may be
important for modulating flux through MCM. In addition, many
putative transporters of unknown substrates are found down-
stream of corrinoid riboswitches and warrant further investiga-
tion (Degnan et al., 2014).
Corrinoid-dependent regulation in the gut microbiome may
also extend beyond riboswitch-regulated genes. Nearly 100
corrinoid riboswitch-regulated ORFs identified in our recent
survey of human gut microbial genomes encode predicted tran-
scriptional regulators and DNA-binding proteins, which them-
selves likely influence the expression of numerous downstream
genes (Degnan et al., 2014). Indeed, genome-wide
transcriptional profiling studies of corrinoid response in the
organohalide-respiring bacterium Dehalococcoides mccartyi
(formerly D. ethenogenes) reveal that many corrinoid-responsive
genes in this organism do not possess corrinoid riboswitches
(Johnson et al., 2009). Multiple bacterial species also use cobal-
amin to directly control the activity of transcriptional regulators
(Klug, 2014). In the best-studied examples, these regulators
leverage the photo-labile nature of the upper ligand of the mole-
cule to respond to light (Cheng et al., 2014; Ortiz-Guerrero et al.,
2011). It is not known whether similar processes exist in mi-
crobes that transition between host-associated and external
habitats or whether these or other transcription factors respond
to the extensive corrinoid structural diversity present in polymi-
crobial environments.
Selective Acquisition of Corrinoids
Unlike other essential small molecules and metals, a single
type of transport mechanism for cobalamin (and other corri-
noids) predominates among bacteria: the ABC-type transporter
BtuFCD in conjunction with the outer membrane receptor BtuB
in Gram-negative bacteria (but see Gopinath et al., 2013).
Although microbes and their corrinoid-dependent enzymes
have been shown to require corrinoids with specific lower
ligands (Mok and Taga, 2013; Reinhold et al., 2012; Yi et al.,
2012), the few BtuBFCD systems that have been characterized
are capable of transporting a variety of corrinoids and their
precursors (Bradbeer et al., 1978; Degnan et al., 2014). This
promiscuity likely allows for effective corrinoid salvaging and
remodeling. However, for microbes without the necessary
enzymes to carry out these processes, developing transporter
specificity for compatible corrinoids could be advantageous.
We recently showed that unlike Proteobacteria (e.g., Escheri-
chia coli), gut Bacteroidetes (which constitute 20%–80% of
the human gut microbiome) often encode multiple copies of
BtuB (Degnan et al., 2014). In Bacteroides thetaiotaomicron,the three copies exhibit a corrinoid-specific functional hierar-
chy. One copy, BtuB2, readily transports cobalamin and six
additional corrinoids tested. Strains lacking this single trans-
porter (with the two additional transporters BtuB1 and BtuB3
intact) are unable to compete with wild-type bacteria in gnoto-
biotic mice with cobalamin as the only available corrinoid
(Degnan et al., 2014; Goodman et al., 2009). These experi-
ments, and in vitro studies, suggest that BtuB1 and BtuB3
have a lower affinity or specificity for cobalamin compared to
BtuB2. Further, the remaining transporters BtuB1 and BtuB3
demonstrate preferences in vitro and in vivo for distinct
corrinoids common in the gut. Strains encoding only BtuB1
outcompete strains encoding BtuB3 when [Ade]Cba and [Bza]
Cba are provided but are outcompeted in the presence of
cobalamin, [2-MeAde]Cba, [5-OMeBza]Cba, and [5-MeBza]
Cba. Our computational analyses suggest that these three
B. thetaiotaomicron transporters represent only 3% of known
BtuB sequence and functional diversity in human gut bacteria.
As such, their relative transport preferences represent a small
portion of the complexity of corrinoid recognition in the human
gut microbiome.
Conclusion
Human-associated commensal microbes engage in elegant and
complex chemical communication and metabolic interactions
(Dorrestein et al., 2014). Manipulation of these pathways pro-
vides an attractive strategy for maximizing the contribution of
themicrobiota to health, but whichmetabolites play fundamental
roles in shaping these communities remains unknown. This
challenge is further compounded by the observation that the
enormous diversity of microbial metabolites remains largely
unexplored (Cimermancic et al., 2014). A surge in genome
sequencing efforts, coupled with new approaches for surveying,
clustering, and annotating chemical metabolites, make this an
exciting era in small molecule discovery (Bouslimani et al.,
2014; Charlop-Powers et al., 2014). However, known small mol-
ecules with well-established, fundamental roles in bacterial
metabolism and gene regulation, including vitamins, should not
be overlooked in this process and may represent promising
opportunities to translate decades of studies of microbial meta-
bolism into effective methods to manipulate the microbiota.
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